Medical Devices

Global Protein Drugs Market Size, Status and Forecast 2018-2025

  • QYR2795271
  • 99 Pages
  • October 2018
  • Medical Devices
Download Sample    Get Discount   
 
A type of drugs made of protein. These drugs usually have large molecular weight with proteincharacteristics.

In 2017, the global Protein Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.

This report focuses on the global Protein Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Protein Drugs development in United States, Europe and China.

The key players covered in this study

Eli Lilly

Abbott Laboratories

UCB Group

Schering-Plough Corporation

Genentech

Johnson?Johnson

Bristol-Myers Squibb

Novo Nordisk

Biogen Idec

Dendreon Corporation

Amgen Inc.

Market segment by Type, the product can be split into

Antibody Drugs

Peptide Hormones

Blood Products

Enzymes

Market segment by Application, split into

Hospitals

Clinics

Other

Market segment by Regions/Countries, this report covers

United States

Europe

China

Japan

Southeast Asia

India

Central & South America

The study objectives of this report are:

To analyze global Protein Drugs status, future forecast, growth opportunity, key market and key players.

To present the Protein Drugs development in United States, Europe and China.

To strategically profile the key players and comprehensively analyze their development plan and strategies.

To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Protein Drugs are as follows:

History Year: 2013-2017

Base Year: 2017

Estimated Year: 2018

Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview

1.1 Study Scope

1.2 Key Market Segments

1.3 Players Covered

1.4 Market Analysis by Type

1.4.1 Global Protein Drugs Market Size Growth Rate by Type (2013-2025)

1.4.2 Antibody Drugs

1.4.3 Peptide Hormones

1.4.4 Blood Products

1.4.5 Enzymes

1.5 Market by Application

1.5.1 Global Protein Drugs Market Share by Application (2013-2025)

1.5.2 Hospitals

1.5.3 Clinics

1.5.4 Other

1.6 Study Objectives

1.7 Years Considered

2 Global Growth Trends

2.1 Protein Drugs Market Size

2.2 Protein Drugs Growth Trends by Regions

2.2.1 Protein Drugs Market Size by Regions (2013-2025)

2.2.2 Protein Drugs Market Share by Regions (2013-2018)

2.3 Industry Trends

2.3.1 Market Top Trends

2.3.2 Market Drivers

2.3.3 Market Opportunities

3 Market Share by Key Players

3.1 Protein Drugs Market Size by Manufacturers

3.1.1 Global Protein Drugs Revenue by Manufacturers (2013-2018)

3.1.2 Global Protein Drugs Revenue Market Share by Manufacturers (2013-2018)

3.1.3 Global Protein Drugs Market Concentration Ratio (CR5 and HHI)

3.2 Protein Drugs Key Players Head office and Area Served

3.3 Key Players Protein Drugs Product/Solution/Service

3.4 Date of Enter into Protein Drugs Market

3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

4.1 Global Protein Drugs Market Size by Type (2013-2018)

4.2 Global Protein Drugs Market Size by Application (2013-2018)

5 United States

5.1 United States Protein Drugs Market Size (2013-2018)

5.2 Protein Drugs Key Players in United States

5.3 United States Protein Drugs Market Size by Type

5.4 United States Protein Drugs Market Size by Application

6 Europe

6.1 Europe Protein Drugs Market Size (2013-2018)

6.2 Protein Drugs Key Players in Europe

6.3 Europe Protein Drugs Market Size by Type

6.4 Europe Protein Drugs Market Size by Application

7 China

7.1 China Protein Drugs Market Size (2013-2018)

7.2 Protein Drugs Key Players in China

7.3 China Protein Drugs Market Size by Type

7.4 China Protein Drugs Market Size by Application

8 Japan

8.1 Japan Protein Drugs Market Size (2013-2018)

8.2 Protein Drugs Key Players in Japan

8.3 Japan Protein Drugs Market Size by Type

8.4 Japan Protein Drugs Market Size by Application

9 Southeast Asia

9.1 Southeast Asia Protein Drugs Market Size (2013-2018)

9.2 Protein Drugs Key Players in Southeast Asia

9.3 Southeast Asia Protein Drugs Market Size by Type

9.4 Southeast Asia Protein Drugs Market Size by Application

10 India

10.1 India Protein Drugs Market Size (2013-2018)

10.2 Protein Drugs Key Players in India

10.3 India Protein Drugs Market Size by Type

10.4 India Protein Drugs Market Size by Application

11 Central & South America

11.1 Central & South America Protein Drugs Market Size (2013-2018)

11.2 Protein Drugs Key Players in Central & South America

11.3 Central & South America Protein Drugs Market Size by Type

11.4 Central & South America Protein Drugs Market Size by Application

12 International Players Profiles

12.1 Eli Lilly

12.1.1 Eli Lilly Company Details

12.1.2 Company Description and Business Overview

12.1.3 Protein Drugs Introduction

12.1.4 Eli Lilly Revenue in Protein Drugs Business (2013-2018)

12.1.5 Eli Lilly Recent Development

12.2 Abbott Laboratories

12.2.1 Abbott Laboratories Company Details

12.2.2 Company Description and Business Overview

12.2.3 Protein Drugs Introduction

12.2.4 Abbott Laboratories Revenue in Protein Drugs Business (2013-2018)

12.2.5 Abbott Laboratories Recent Development

12.3 UCB Group

12.3.1 UCB Group Company Details

12.3.2 Company Description and Business Overview

12.3.3 Protein Drugs Introduction

12.3.4 UCB Group Revenue in Protein Drugs Business (2013-2018)

12.3.5 UCB Group Recent Development

12.4 Schering-Plough Corporation

12.4.1 Schering-Plough Corporation Company Details

12.4.2 Company Description and Business Overview

12.4.3 Protein Drugs Introduction

12.4.4 Schering-Plough Corporation Revenue in Protein Drugs Business (2013-2018)

12.4.5 Schering-Plough Corporation Recent Development

12.5 Genentech

12.5.1 Genentech Company Details

12.5.2 Company Description and Business Overview

12.5.3 Protein Drugs Introduction

12.5.4 Genentech Revenue in Protein Drugs Business (2013-2018)

12.5.5 Genentech Recent Development

12.6 Johnson?Johnson

12.6.1 Johnson?Johnson Company Details

12.6.2 Company Description and Business Overview

12.6.3 Protein Drugs Introduction

12.6.4 Johnson?Johnson Revenue in Protein Drugs Business (2013-2018)

12.6.5 Johnson?Johnson Recent Development

12.7 Bristol-Myers Squibb

12.7.1 Bristol-Myers Squibb Company Details

12.7.2 Company Description and Business Overview

12.7.3 Protein Drugs Introduction

12.7.4 Bristol-Myers Squibb Revenue in Protein Drugs Business (2013-2018)

12.7.5 Bristol-Myers Squibb Recent Development

12.8 Novo Nordisk

12.8.1 Novo Nordisk Company Details

12.8.2 Company Description and Business Overview

12.8.3 Protein Drugs Introduction

12.8.4 Novo Nordisk Revenue in Protein Drugs Business (2013-2018)

12.8.5 Novo Nordisk Recent Development

12.9 Biogen Idec

12.9.1 Biogen Idec Company Details

12.9.2 Company Description and Business Overview

12.9.3 Protein Drugs Introduction

12.9.4 Biogen Idec Revenue in Protein Drugs Business (2013-2018)

12.9.5 Biogen Idec Recent Development

12.10 Dendreon Corporation

12.10.1 Dendreon Corporation Company Details

12.10.2 Company Description and Business Overview

12.10.3 Protein Drugs Introduction

12.10.4 Dendreon Corporation Revenue in Protein Drugs Business (2013-2018)

12.10.5 Dendreon Corporation Recent Development

12.11 Amgen Inc.

13 Market Forecast 2018-2025

13.1 Market Size Forecast by Regions

13.2 United States

13.3 Europe

13.4 China

13.5 Japan

13.6 Southeast Asia

13.7 India

13.8 Central & South America

13.9 Market Size Forecast by Product (2018-2025)

13.10 Market Size Forecast by Application (2018-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

12.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Disclaimer

15.3 Author Details

List of Tables and Figures

Table Protein Drugs Key Market Segments

Table Key Players Protein Drugs Covered

Table Global Protein Drugs Market Size Growth Rate by Type 2013-2025 (Million US$)

Figure Global Protein Drugs Market Size Market Share by Type 2013-2025

Figure Antibody Drugs Figures

Table Key Players of Antibody Drugs

Figure Peptide Hormones Figures

Table Key Players of Peptide Hormones

Figure Blood Products Figures

Table Key Players of Blood Products

Figure Enzymes Figures

Table Key Players of Enzymes

Table Global Protein Drugs Market Size Growth by Application 2013-2025 (Million US$)

Figure Hospitals Case Studies

Figure Clinics Case Studies

Figure Other Case Studies

Figure Protein Drugs Report Years Considered

Table Global Protein Drugs Market Size 2013-2025 (Million US$)

Figure Global Protein Drugs Market Size and Growth Rate 2013-2025 (Million US$)

Table Global Protein Drugs Market Size by Regions 2013-2025 (Million US$)

Table Global Protein Drugs Market Size by Regions 2013-2018 (Million US$)

Table Global Protein Drugs Market Share by Regions 2013-2018

Figure Global Protein Drugs Market Share by Regions 2013-2018

Figure Global Protein Drugs Market Share by Regions 2018

Table Market Top Trends

Table Global Protein Drugs Revenue by Manufacturers (2013-2018) (Million US$)

Table Global Protein Drugs Market Share by Manufacturers (2013-2018)

Figure Global Protein Drugs Market Share by Manufacturers in 2018

Table Global Protein Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)

Table Key Players Head office and Area Served

Table Key Players Protein Drugs Product/Solution/Service

Table Date of Enter into Protein Drugs Market

Table Mergers & Acquisitions, Expansion Plans

Table Global Protein Drugs Market Size by Type (2013-2018) (Million US$)

Table Global Protein Drugs Market Size Share by Type (2013-2018)

Figure Global Protein Drugs Market Size Market Share by Type (2013-2018)

Table Global Protein Drugs Market Size by Application (2013-2018) (Million US$)

Table Global Protein Drugs Market Size Share by Application (2013-2018)

Figure Global Protein Drugs Market Size Market Share by Application (2013-2018)

Figure Global Protein Drugs Revenue Market Share by Application in 2017

Figure United States Protein Drugs Market Size 2013-2018 (Million US$)

Table United States Key Players Protein Drugs Revenue (2017-2018) (Million US$)

Table United States Key Players Protein Drugs Market Share (2017-2018)

Table United States Protein Drugs Market Size by Type (2013-2018) (Million US$)

Table United States Protein Drugs Market Share by Type (2013-2018)

Table United States Protein Drugs Market Size by Application (2013-2018) (Million US$)

Table United States Protein Drugs Market Share by Application (2013-2018)

Figure Europe Protein Drugs Market Size 2013-2018 (Million US$)

Table Europe Key Players Protein Drugs Revenue (2017-2018) (Million US$)

Table Europe Key Players Protein Drugs Market Share (2017-2018)

Table Europe Protein Drugs Market Size by Type (2013-2018) (Million US$)

Table Europe Protein Drugs Market Share by Type (2013-2018)

Table Europe Protein Drugs Market Size by Application (2013-2018) (Million US$)

Table Europe Protein Drugs Market Share by Application (2013-2018)

Figure China Protein Drugs Market Size 2013-2018 (Million US$)

Table China Key Players Protein Drugs Revenue (2017-2018) (Million US$)

Table China Key Players Protein Drugs Market Share (2017-2018)

Table China Protein Drugs Market Size by Type (2013-2018) (Million US$)

Table China Protein Drugs Market Share by Type (2013-2018)

Table China Protein Drugs Market Size by Application (2013-2018) (Million US$)

Table China Protein Drugs Market Share by Application (2013-2018)

Figure Japan Protein Drugs Market Size 2013-2018 (Million US$)

Table Japan Key Players Protein Drugs Revenue (2017-2018) (Million US$)

Table Japan Key Players Protein Drugs Market Share (2017-2018)

Table Japan Protein Drugs Market Size by Type (2013-2018) (Million US$)

Table Japan Protein Drugs Market Share by Type (2013-2018)

Table Japan Protein Drugs Market Size by Application (2013-2018) (Million US$)

Table Japan Protein Drugs Market Share by Application (2013-2018)

Figure Southeast Asia Protein Drugs Market Size 2013-2018 (Million US$)

Table Southeast Asia Key Players Protein Drugs Revenue (2017-2018) (Million US$)

Table Southeast Asia Key Players Protein Drugs Market Share (2017-2018)

Table Southeast Asia Protein Drugs Market Size by Type (2013-2018) (Million US$)

Table Southeast Asia Protein Drugs Market Share by Type (2013-2018)

Table Southeast Asia Protein Drugs Market Size by Application (2013-2018) (Million US$)

Table Southeast Asia Protein Drugs Market Share by Application (2013-2018)

Figure India Protein Drugs Market Size 2013-2018 (Million US$)

Table India Key Players Protein Drugs Revenue (2017-2018) (Million US$)

Table India Key Players Protein Drugs Market Share (2017-2018)

Table India Protein Drugs Market Size by Type (2013-2018) (Million US$)

Table India Protein Drugs Market Share by Type (2013-2018)

Table India Protein Drugs Market Size by Application (2013-2018) (Million US$)

Table India Protein Drugs Market Share by Application (2013-2018)

Figure Central & South America Protein Drugs Market Size 2013-2018 (Million US$)

Table Central & South America Key Players Protein Drugs Revenue (2017-2018) (Million US$)

Table Central & South America Key Players Protein Drugs Market Share (2017-2018)

Table Central & South America Protein Drugs Market Size by Type (2013-2018) (Million US$)

Table Central & South America Protein Drugs Market Share by Type (2013-2018)

Table Central & South America Protein Drugs Market Size by Application (2013-2018) (Million US$)

Table Central & South America Protein Drugs Market Share by Application (2013-2018)

Table Eli Lilly Company Details

Table Eli Lilly Revenue in Protein Drugs Business (2013-2018) (Million US$)

Figure Eli Lilly Revenue Growth Rate in Protein Drugs Business (2013-2018)

Table Eli Lilly Recent Development

Table Abbott Laboratories Company Details

Table Abbott Laboratories Revenue in Protein Drugs Business (2013-2018)(Million US$)

Figure Abbott Laboratories Revenue Growth Rate in Protein Drugs Business (2013-2018)

Table Abbott Laboratories Recent Development

Table UCB Group Company Details

Table UCB Group Revenue in Protein Drugs Business (2013-2018)(Million US$)

Figure UCB Group Revenue Growth Rate in Protein Drugs Business (2013-2018)

Table UCB Group Recent Development

Table Schering-Plough Corporation Company Details

Table Schering-Plough Corporation Revenue in Protein Drugs Business (2013-2018)(Million US$)

Figure Schering-Plough Corporation Revenue Growth Rate in Protein Drugs Business (2013-2018)

Table Schering-Plough Corporation Recent Development

Table Genentech Company Details

Table Genentech Revenue in Protein Drugs Business (2013-2018)(Million US$)

Figure Genentech Revenue Growth Rate in Protein Drugs Business (2013-2018)

Table Genentech Recent Development

Table Johnson?Johnson Company Details

Table Johnson?Johnson Revenue in Protein Drugs Business (2013-2018)(Million US$)

Figure Johnson?Johnson Revenue Growth Rate in Protein Drugs Business (2013-2018)

Table Johnson?Johnson Recent Development

Table Bristol-Myers Squibb Company Details

Table Bristol-Myers Squibb Revenue in Protein Drugs Business (2013-2018)(Million US$)

Figure Bristol-Myers Squibb Revenue Growth Rate in Protein Drugs Business (2013-2018)

Table Bristol-Myers Squibb Recent Development

Table Novo Nordisk Company Details

Table Novo Nordisk Revenue in Protein Drugs Business (2013-2018)(Million US$)

Figure Novo Nordisk Revenue Growth Rate in Protein Drugs Business (2013-2018)

Table Novo Nordisk Recent Development

Table Biogen Idec Company Details

Table Biogen Idec Revenue in Protein Drugs Business (2013-2018)(Million US$)

Figure Biogen Idec Revenue Growth Rate in Protein Drugs Business (2013-2018)

Table Biogen Idec Recent Development

Table Dendreon Corporation Company Details

Table Dendreon Corporation Revenue in Protein Drugs Business (2013-2018)(Million US$)

Figure Dendreon Corporation Revenue Growth Rate in Protein Drugs Business (2013-2018)

Table Dendreon Corporation Recent Development

Table Amgen Inc. Company Details

Table Global Protein Drugs Market Size by Regions (Million US$) 2018-2025

Figure Global Protein Drugs Market Size Share by Regions (2018-2025)

Figure Global Protein Drugs Market Size Share by Regions in 2025

Figure United States Protein Drugs Market Size Forecast (2018-2025)(Million USD)

Figure Europe Protein Drugs Market Size Forecast (2018-2025)(Million USD)

Figure China Protein Drugs Market Size Forecast (2018-2025)(Million USD)

Figure Japan Protein Drugs Market Size Forecast (2018-2025)(Million USD)

Figure Southeast Asia Protein Drugs Market Size Forecast (2018-2025)(Million USD)

Figure India Protein Drugs Market Size Forecast (2018-2025)(Million USD)

Figure Central & South America Protein Drugs Market Size Forecast (2018-2025)(Million USD)

Table Global Protein Drugs Market Size by Product (2018-2025) (Million US$)

Figure Global Protein Drugs Market Size by Product (2018-2025)

Figure Global Protein Drugs Market Size by Product in 2025

Table Global Protein Drugs Market Size by Application (2018-2025) (Million US$)

Figure Global Protein Drugs Market Size by Application (2018-2025)

Figure Global Protein Drugs Market Size by Application in 2025

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Similar Reports

Medical Implants Market By Type (Orthopedic Implants, cardiac implants, Stents, Spinal Implants, Neurostimulators, dental implants, Breast Implants, facial Implants) and By Materials (Metallic, Ceramic, Polymers, Natural) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022

Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...

  • Publish Date: August 21, 2016
  • $5370
Ostomy Drainage Bags Market by Type (Colostomy Bags, Ileostomy Bags, Urostomy Bags, Continent Urostomy Bags, and Continent Ileostomy Bags) - Global Opportunity Analysis and Industry Forecast, 2014-2022

Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...

  • Publish Date: December 1, 2016
  • $5370